Suven creates value through demerger
The pharmaceutical component of the company which was carve-out in January got listed today , This is another demerger which was value accretive Pre Demerger Mkt cap was less than INR 3000 crore now separate companies have combined market cap ~INR 5000 crore
You can read a previous analysis of the company here
As far as scorecard is concerned , we would b…
Keep reading with a 7-day free trial
Subscribe to Tankrich to keep reading this post and get 7 days of free access to the full post archives.
